2021 annual financial data
Anixa Biosciences 2021 Operating margin
Direct answer
Operating margin was -2,565.56%.
Operating income was -13,135,692 USD and net income was -12,946,631 USD.
Operating cash flow was -4,938,000 USD.
Get free Anixa Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 512,000 USD
- Operating income
- -13,135,692 USD
- Net income
- -12,946,631 USD
- Operating cash flow
- -4,938,000 USD